Dasatinib plus capecitabine (Cap) for progressive advanced breast cancer (ABC): Phase I study CA180004

Authors
Category Primary study
JournalJournal of Clinical Oncology
Year 2009
This article has no abstract
Epistemonikos ID: 46a2b424e1b767de1cd11deaedb100084e084051
First added on: Mar 01, 2025